Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Joos, S.
Right arrow Articles by Lichter, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Joos, S.
Right arrow Articles by Lichter, P.
[Cancer Research 60, 549-552, February 1, 2000]
© 2000 American Association for Cancer Research

Advances in Brief

Genomic Imbalances Including Amplification of the Tyrosine Kinase Gene JAK2 in CD30+ Hodgkin Cells1

Stefan Joos2, Manfred Küpper, Sibylle Ohl, Frederike von Bonin, Gunhild Mechtersheimer, Martin Bentz, Peter Marynen, Peter Möller, Michael Pfreundschuh, Lorenz Trümper and Peter Lichter

Deutsches Krebsforschungszentrum, Abteilung Organisation Komplexer Genome (H0700), D-69120 Heidelberg [S. J., M. K., S. O., P. L.]; Universitätskliniken des Saarlandes, Innere Medizin I, D-66421 Homburg/Saar [F. v. B., M. P., L. T.]; Pathologisches Institut, Universität Heidelberg, D-69120 Heidelberg [G. M.]; Abteilung Innere Medizin III, D-89081 Ulm [M. B.]; Human Genome Laboratory, B-3000 Leuven [P. Ma.]; Abteilung für Pathologie des Universitätsklinikums Ulm, D-89081 Ulm [P. Mö.], Germany

Comparative genomic hybridization was applied for a comprehensive screening of frequently occurring net gains and losses of chromosomal subregions in small populations of CD30+ Hodgkin cells and their morphological variants. In 12 Hodgkin’s lymphomas, recurrent gains were detected on chromosomal arms 2p, 9p, and 12q (in six, four, and five tumors, respectively) and distinct high-level amplifications were identified on chromosomal bands 4p16, 4q23-q24, and 9p23-p24. In Hodgkin cells with 9p23-p24 amplification, fluorescence in situ hybridization revealed an increased copy number of chromosomal sequences spanning the tyrosine kinase gene JAK2. Several of the imbalances described, in particular a gain in chromosomal arm 9p that includes JAK2 amplification, are similar to the genomic changes detected in primary mediastinal B-cell lymphoma.




This article has been cited by other articles:


Home page
 haematolHome page
T. Feys, B. Poppe, K. De Preter, N. Van Roy, B. Verhasselt, P. De Paepe, A. De Paepe, and F. Speleman
A detailed inventory of DNA copy number alterations in four commonly used Hodgkin's lymphoma cell lines
Haematologica, July 1, 2007; 92(7): 913 - 920.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. I. Martin-Subero, W. Klapper, A. Sotnikova, E. Callet-Bauchu, L. Harder, C. Bastard, R. Schmitz, S. Grohmann, J. Hoppner, J. Riemke, et al.
Chromosomal Breakpoints Affecting Immunoglobulin Loci Are Recurrent in Hodgkin and Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Cancer Res., November 1, 2006; 66(21): 10332 - 10338.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Kasugai, H. Tagawa, Y. Kameoka, Y. Morishima, S. Nakamura, and M. Seto
Identification of CCND3 and BYSL as Candidate Targets for the 6p21 Amplification in Diffuse Large B-Cell Lymphoma
Clin. Cancer Res., December 1, 2005; 11(23): 8265 - 8272.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. L. Levine, M. Loriaux, B. J. P. Huntly, M. L. Loh, M. Beran, E. Stoffregen, R. Berger, J. J. Clark, S. G. Willis, K. T. Nguyen, et al.
The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia
Blood, November 15, 2005; 106(10): 3377 - 3379.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. Re, R. Kuppers, and V. Diehl
Molecular Pathogenesis of Hodgkin's Lymphoma
J. Clin. Oncol., September 10, 2005; 23(26): 6379 - 6386.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Re, R. K. Thomas, K. Behringer, and V. Diehl
From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential
Blood, June 15, 2005; 105(12): 4553 - 4560.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
I. Melzner, A. J. Bucur, S. Bruderlein, K. Dorsch, C. Hasel, T. F. E. Barth, F. Leithauser, and P. Moller
Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line
Blood, March 15, 2005; 105(6): 2535 - 2542.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. J. Savage, S. Monti, J. L. Kutok, G. Cattoretti, D. Neuberg, L. de Leval, P. Kurtin, P. D. Cin, C. Ladd, F. Feuerhake, et al.
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
Blood, December 1, 2003; 102(12): 3871 - 3879.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. Rosenwald, G. Wright, K. Leroy, X. Yu, P. Gaulard, R. D. Gascoyne, W. C. Chan, T. Zhao, C. Haioun, T. C. Greiner, et al.
Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma
J. Exp. Med., September 15, 2003; 198(6): 851 - 862.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Re, P. Starostik, N. Massoudi, A. Staratschek-Jox, V. Dries, R. K. Thomas, V. Diehl, and J. Wolf
Allelic Losses on Chromosome 6q25 in Hodgkin and Reed Sternberg Cells
Cancer Res., May 15, 2003; 63(10): 2606 - 2609.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. F. E. Barth, J. I. Martin-Subero, S. Joos, C. K. Menz, C. Hasel, G. Mechtersheimer, R. M. Parwaresch, P. Lichter, R. Siebert, and P. Moller
Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma
Blood, May 1, 2003; 101(9): 3681 - 3686.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Copie-Bergman, M.-L. Boulland, C. Dehoulle, P. Moller, J.-P. Farcet, M. J. S. Dyer, C. Haioun, P.-H. Romeo, P. Gaulard, and K. Leroy
Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma
Blood, April 1, 2003; 101(7): 2756 - 2761.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. M. Maggio, A. van den Berg, D. de Jong, A. Diepstra, and S. Poppema
Low Frequency of FAS Mutations in Reed-Sternberg Cells of Hodgkin's Lymphoma
Am. J. Pathol., January 1, 2003; 162(1): 29 - 35.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Franke, I. Wlodarska, B. Maes, P. Vandenberghe, R. Achten, A. Hagemeijer, and C. De Wolf-Peeters
Comparative Genomic Hybridization Pattern Distinguishes T-Cell/Histiocyte-Rich B-Cell Lymphoma from Nodular Lymphocyte Predominance Hodgkin's Lymphoma
Am. J. Pathol., November 1, 2002; 161(5): 1861 - 1867.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Joos, C. K. Menz, G. Wrobel, R. Siebert, S. Gesk, S. Ohl, G. Mechtersheimer, L. Trumper, P. Moller, P. Lichter, et al.
Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2
Blood, February 15, 2002; 99(4): 1381 - 1387.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. I. Martin-Subero, S. Gesk, L. Harder, T. Sonoki, P. W. Tucker, B. Schlegelberger, W. Grote, F. J. Novo, M. J. Calasanz, M. L. Hansmann, et al.
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma
Blood, February 15, 2002; 99(4): 1474 - 1477.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Satterwhite, T. Sonoki, T. G. Willis, L. Harder, R. Nowak, E. L. Arriola, H. Liu, H. P. Price, S. Gesk, D. Steinemann, et al.
The BCL11 gene family: involvement of BCL11A in lymphoid malignancies
Blood, December 1, 2001; 98(12): 3413 - 3420.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. Leithauser, M. Bauerle, M. Q. Huynh, and P. Moller
Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma
Blood, November 1, 2001; 98(9): 2762 - 2770.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Kube, U. Holtick, M. Vockerodt, T. Ahmadi, B. Haier, I. Behrmann, P. C. Heinrich, V. Diehl, and H. Tesch
STAT3 is constitutively activated in Hodgkin cell lines
Blood, August 1, 2001; 98(3): 762 - 770.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Franke, I. Wlodarska, B. Maes, P. Vandenberghe, J. Delabie, A. Hagemeijer, and C. De Wolf-Peeters
Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances
Blood, March 15, 2001; 97(6): 1845 - 1853.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.